Concomitantly, as compared to COV patients, we report that COV/CA patients have higher frequency of activated HLA-DR+ and CD38+/HLA-DR+ T cells, which is in line with enhanced COVID-19 severity (29). This evidence concerns the gene CD38 and COVID-19.